Skip to main content
. Author manuscript; available in PMC: 2013 Sep 2.
Published in final edited form as: Neuropeptides. 2012 Feb 10;46(2):81–91. doi: 10.1016/j.npep.2012.01.001

Figure 4.

Figure 4

Effects on mRNA levels of galanin (GAL), tyrosine hydroxylase (TH), galanin receptors type 1, 2, and 3 (GalR1, GalR2, GalR3), and β-Actin (Parts A-F) in the A1/C1 cell-body region in the ventral brainstem following chronic administration (for two weeks) of one of three AD drugs -- phenelzine (PHE), desipramine (DMI), and paroxetine (PAR) -- or vehicle (VEH). All other details as described in legend for Figure 2.